Produkty 473921-12-9

CAS 473921-12-9 występuje w naszej ofercie pod nazwami: Lersivirine/ 99.26% (existing batch purity), Lersivirine, Lersivirine, 98%, 3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile, 99%, 99%, Lersivirine, 98.38%. Oferty producentów: TargetMol, GLPBio, Biosynth, Thermo Scientific (Acros), Chemat. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso), 50 mg.

Lersivirine/ 99.26% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 452,11
Zobacz produkt
Lersivirine
GLPBio, Biosynth
  • opakowanie: 10mg, 25mg, 5mg, 10mM (in 1ml dmso)
  • Warianty: 7
od 831,06
Zobacz produkt
Lersivirine, 98%
Thermo Scientific (Acros)
  • opakowanie: 100MG
  • Warianty: 1
od 2400,95
Zobacz produkt
3-Cyano-5-[[3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl]oxy]benzonitrile, 99%, 99%
Chemat
  • opakowanie: 25mg, 50mg
  • Warianty: 2
od 573,20
Zobacz produkt
Lersivirine, 98.38%
MedChemExpress
  • opakowanie: 50 mg, 10 mg, 25 mg, 5 mg
  • Warianty: 5
od 663,35
Zobacz produkt
Lersivirine, 99%
Ambeed
  • opakowanie: 100mg, 250mg
  • Warianty: 2
od 2272,75
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile (CAS 473921-12-9) to związek chemiczny o wzorze sumarycznym C17H18N4O2 i masie molowej 310.35 g/mol. Nazwa systematyczna IUPAC: 5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile. InChIKey: MCPUZZJBAHRIPO-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC17H18N4O2
Masa molowa310.35 g/mol
Nazwa IUPAC5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile
InChIKeyMCPUZZJBAHRIPO-UHFFFAOYSA-N
SMILESCCC1=C(C(=NN1CCO)CC)OC2=CC(=CC(=C2)C#N)C#N

Dane obliczone przez PubChem (NCBI)

Synonimy: Lersivirine, Lersivirina, lersivirinum, 5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile, 5-((3,5-diethyl-1-(2-hydroxyethyl)-1H-pyrazol-4-yl)oxy)isophthalonitrile, ZZE, Lersivirine [USAN], Lersivirine [USAN:INN], 2won, LERSIVIRINE [INN]
Izomery (ten sam wzór sumaryczny)
ethyl 2-[2-(dimethylamino)pyrimidin-4-yl]-1H-indole-5-carboxylate C17H18N4O2
3-benzyl-7-cyclopentylpurine-2,6-dione C17H18N4O2
ethyl 4-[(E)-2-(dimethylamino)ethenyl]pyrimido[1,2-a]benzimidazole-3-carboxylate C17H18N4O2
5-[5-(4,4-dimethylcyclohexen-1-yl)-1,2,4-oxadiazol-3-yl]-1,3-dihydrobenzimidazol-2-one C17H18N4O2
2-[[4-(hydroxymethyl)-1H-imidazol-5-yl]methyl]-5-methyl-3,4-dihydropyrido[4,3-b]indol-1-one C17H18N4O2
4-acetamido-N-[(E)-1-(3-aminophenyl)ethylideneamino]benzamide C17H18N4O2
6-hydroxy-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one C17H18N4O2
7-hydroxy-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one C17H18N4O2
5-[[8-(dimethylamino)-7-methylquinolin-5-yl]methyl]-1H-pyrimidine-2,4-dione C17H18N4O2
5-[[8-(dimethylamino)-7-methylquinolin-5-yl]methyl]-1H-pyrimidine-2,4-dione C17H18N4O2
7-methoxy-4-(2-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)-1,3-dihydroquinoxalin-2-one C17H18N4O2
ethyl 4-(benzylamino)-1-methylpyrazolo[3,4-b]pyridine-5-carboxylate C17H18N4O2